Federal Register / Vol. 70, No. 224 / Tuesday, November 22, 2005 / Notices 70621 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Attn: Desk Officer for 

ACF, E-mail address: 

Katherine_T._Astrich@omb.eop.gov. 

Dated: November 16, 2005. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 05–23084 Filed 11–21–05; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Invitation to Comment on Proposed 

Data Composites and Potential 

Performance Areas and Measures for 

the Child and Family Services Review 

AGENCY: Children’s Bureau (CB), 

Administration on Children, Youth and 

Families (ACYF), Administration for 

Children and Families (ACF), 

Department of Health and Human 

Services. 

ACTION: Correction notice to the 

following action: Invitation to comment 

on proposed data composites and 

potential performance areas and 

measures for the Federal Child and 

Family Services Review (CFSR). 

Corrective Action: The initial 

publication in the Federal Register on 

November 7, 2005 (70 FR 67479) 

inadvertently omitted the date that the 

comments are due to the Children’s 

Bureau. The due date for comments is 

December 7, 2005. 

Dated: November 17, 2005. 

Reginia H. Ryan, 

Director, Executive Secretariat, ACYF. 

[FR Doc. 05–23206 Filed 11–21–05; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2005N–0153] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Regulations for In Vivo 

Radiopharmaceuticals Used for 

Diagnosis and Monitoring 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘Regulations For In Vivo 

Radiopharmaceuticals Used For 

Diagnosis and Monitoring’’ has been 

approved by the Office of Management 

and Budget (OMB) under the Paperwork 

Reduction Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Karen Nelson, Office of Management 

Programs (HFA–250), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–1482. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of May 3, 2005 (70 FR 

22887), the agency announced that the 

proposed information collection had 

been submitted to OMB for review and 

clearance under 44 U.S.C. 3507. An 

agency may not conduct or sponsor, and 

a person is not required to respond to, 

a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0409. The 

approval expires on October 31, 2008. A 

copy of the supporting statement for this 

information collection is available on 

the Internet at http://www.fda.gov/ 

ohrms/dockets. 

Dated: November 15, 2005. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. 05–23039 Filed 11–21–05; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2005N–0343] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Guidance for 

Requesting an Extension to Use 

Existing Label Stock After the Trans 

Fat Labeling Effective Date of January 

1, 2006 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the proposed collection of information 

associated with the guidance document 

entitled ‘‘Requesting an Extension to 

Use Existing Label Stock After the Trans 

Fat Labeling Effective Date of January 1, 

2006.’’ Elsewhere in this issue of the 

Federal Register, FDA is publishing a 

notice announcing the Office of 

Management and Budget (OMB’s) 

approval of this collection of 

information (OMB control number 

0910–0571). Since this was an 

emergency approval that expires on 

January 1, 2006, FDA is following the 

normal PRA clearance procedures by 

issuing this notice. 

DATES: Submit written or electronic 

comments on the collection of 

information by January 23, 2006. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to: http://www.fda.gov/ 

dockets/ecomments. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: 

Peggy Robbins, Office of Management 

Programs (HFA–250), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–1223.